Sequence / Chemical Identity
Peptide Length: 39 amino acids
Structural Class: Synthetic linear peptide; dual incretin receptor agonist (GIP and GLP-1 receptors) with a C20 fatty diacid moiety for albumin binding and extended half-life
Sequence / Chemical Identity
Peptide Length: 39 amino acids
Structural Class: Synthetic linear peptide; dual incretin receptor agonist (GIP and GLP-1 receptors) with a C20 fatty diacid moiety for albumin binding and extended half-life
Price range: $55.00 through $100.00
Molecular Data
Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈ (free base; may vary slightly depending on salt form)
Molecular Weight: ~4,813 g/mol
CAS Number: 2023788-19-2
Receptor / Pathway Targets
Primary Research Targets:
Glucose-dependent insulinotropic polypeptide receptor (GIPR)
Glucagon-like peptide-1 receptor (GLP-1R)
Investigated Pathways:
Glucose-dependent insulin secretion
Glucagon suppression
Gastric emptying delay
Appetite regulation and satiety signaling
Body weight regulation via central and peripheral mechanisms
Purity Standard
≥98% (HPLC) (typical for pharmaceutical-grade material; research-grade may vary)
Appearance
White to off-white lyophilized powder
Storage
Store at −20°C (lyophilized form)
Protect from light and moisture
Reconstituted solutions are typically stored refrigerated or frozen and used within a limited timeframe to minimize degradation
Regulatory Status
Approved for medical use in multiple regions for type 2 diabetes and chronic weight management (under specific brand formulations)
Also available as a reference standard or research material in laboratory settings
Use outside approved indications is subject to regulatory oversight
| Weight | 10mg, 20mg, 30mg, 50mg |
|---|
